Interleukin 2 Receptor Targeted Immunotherapy — Update and Attempt at Synthesis
- 1 January 1989
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Interleukin-2 Receptor β Chain Gene: Generation of Three Receptor Forms by Cloned Human α and β Chain cDNA'sScience, 1989
- PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL IN MURINE RECIPIENTS TREATED WITH A DIPHTHERIA TOXIN RELATED INTERLEUKIN-2 FUSION PROTEINTransplantation, 1989
- INTERLEUKIN-2-DIPHTHERIA TOXIN FUSION PROTEIN PROLONGS MURINE ISLET CELL ENGRAFTMENTTransplantation, 1989
- PROLONGATION OF PRIMATE RENAL ALLOGRAFT SURVIVAL BY ANTI-TAC, AN ANTI-HUMAN IL-2 RECEPTOR MONOCLONAL ANTIBODYTransplantation, 1989
- AGONISTIC AND ANTAGONISTIC INTERACTIONS OF ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODIES IN RAT RECIPIENTS OF CARDIAC ALLOGRAFTSTransplantation, 1989
- Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapyEuropean Journal of Immunology, 1988
- TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH MONOCLONAL ANTIBODY TO IL-2 RECEPTORThe Lancet, 1988
- Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.The Journal of Experimental Medicine, 1988
- PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2The Lancet, 1987
- Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity ConditionsScience, 1986